A team of investigators from Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH), and the Broad Institute of MIT and Harvard have developed a non-invasive genetic test that can ...

Noninvasive prenatal screening, involving analysis of fetal cell-free DNA in maternal blood, is currently available only for a small number of conditions caused by large chromosomal abnormalities.

A research team has developed an innovative screening test. With a blood sample from the expectant mother, they can scrutinize all the genes in the fetus. The findings indicate that the new test, ...

Non-invasive prenatal screening techniques can detect chromosomal abnormalities including Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13). These ...

Myriad Genetics, Inc. has launched a new educational website called "Know More Sooner," aimed at providing detailed information about reproductive and prenatal genetic testing. The site seeks to ...

Myriad Genetics (MYGN) continues to empower parents with increased access to prenatal testing. SneakPeek is now available over the counter in more than 8,800 retail locations nationwide. The product ...

Please provide your email address to receive an email when new articles are posted on . Cell-free fetal antigen analyses had 100% consistency for 465 calls on antigens in which women were ...

Expecting mothers typically opt for prenatal genetic testing during their first and third trimesters. Performed with a sample of the mother's blood, this test looks for fetal aneuploidy, an abnormal ...

In the past, parents-to-be concerned with the genetic state of their gestating offspring had to test both the mother’s and father’s blood in order to determine what traits the child would likely ...